Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Moreau

Showing results (401-410 of 570) with videos related to

Pageof 57
Sort By:
Leukemia|February 16, 2011
Phase I study of the anti insulin-like growth factor 1 receptor (IGF-1R) monoclonal antibody, AVE1642, as single agent and in combination with bortezomib in patients with relapsed multiple myelomaP Moreau, F Cavallo, X Leleu, et al.
British Journal of Cancer|November 11, 2010
BH3-only protein Bik is involved in both apoptosis induction and sensitivity to oxidative stress in multiple myelomaL Bodet, E Ménoret, G Descamps, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: a randomized study from the Groupe d'Etude des Lymphomes Folliculaires. Groupe d'Etude des Lymphomes de l'AdulteP Brice, Y Bastion, E Lepage, et al.
Plos One|March 13, 2018
Validation of a microRNA target site polymorphism in H3F3B that is potentially associated with a broad schizophrenia phenotypeWilliam Manley, Michael P Moreau, Marco Azaro, et al.
Asia-Pacific Journal of Public Health|January 1, 1989
Hepatitis B infection in Vanuatu: age of acquisition of infection and possible routes of transmissionR Taylor, B Montaville, S Levy, et al.
The International Journal of Biochemistry & Cell Biology|August 29, 2009
Bioenergetics of lung tumors: alteration of mitochondrial biogenesis and respiratory capacityN Bellance, G Benard, F Furt, et al.
Cancer|October 8, 1998
Ovarian transposition by laparoscopy before radiotherapy in the treatment of Hodgkin's diseaseJ M Classe, M Mahé, P Moreau, et al.
Bone Marrow Transplantation|July 1, 1997
Prognostic factors for survival after high-dose therapy and autologous stem cell transplantation for patients with relapsing Hodgkin's disease: analysis of 280 patients from the French registry. Société Française de Greffe de MoëlleP Brice, R Bouabdallah, P Moreau, et al.
Anticancer Research|November 4, 2000
Drug-induced inhibition of the peripheral-type benzodiazepine receptor expression and cell proliferation in human breast cancer cellsV Papadopoulos, A Kapsis, H Li, et al.
The Journal of Clinical Endocrinology and Metabolism|March 7, 2001
Bim-23244, a somatostatin receptor subtype 2- and 5-selective analog with enhanced efficacy in suppressing growth hormone (GH) from octreotide-resistant human GH-secreting adenomasA Saveanu, G Gunz, H Dufour, et al.
Pageof 57

Showing results (401-410 of 570) with videos related to

Sort By:
Pageof 57
Leukemia|February 16, 2011
Phase I study of the anti insulin-like growth factor 1 receptor (IGF-1R) monoclonal antibody, AVE1642, as single agent and in combination with bortezomib in patients with relapsed multiple myelomaP Moreau, F Cavallo, X Leleu, et al.
British Journal of Cancer|November 11, 2010
BH3-only protein Bik is involved in both apoptosis induction and sensitivity to oxidative stress in multiple myelomaL Bodet, E Ménoret, G Descamps, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: a randomized study from the Groupe d'Etude des Lymphomes Folliculaires. Groupe d'Etude des Lymphomes de l'AdulteP Brice, Y Bastion, E Lepage, et al.
Plos One|March 13, 2018
Validation of a microRNA target site polymorphism in H3F3B that is potentially associated with a broad schizophrenia phenotypeWilliam Manley, Michael P Moreau, Marco Azaro, et al.
Asia-Pacific Journal of Public Health|January 1, 1989
Hepatitis B infection in Vanuatu: age of acquisition of infection and possible routes of transmissionR Taylor, B Montaville, S Levy, et al.
The International Journal of Biochemistry & Cell Biology|August 29, 2009
Bioenergetics of lung tumors: alteration of mitochondrial biogenesis and respiratory capacityN Bellance, G Benard, F Furt, et al.
Cancer|October 8, 1998
Ovarian transposition by laparoscopy before radiotherapy in the treatment of Hodgkin's diseaseJ M Classe, M Mahé, P Moreau, et al.
Bone Marrow Transplantation|July 1, 1997
Prognostic factors for survival after high-dose therapy and autologous stem cell transplantation for patients with relapsing Hodgkin's disease: analysis of 280 patients from the French registry. Société Française de Greffe de MoëlleP Brice, R Bouabdallah, P Moreau, et al.
Anticancer Research|November 4, 2000
Drug-induced inhibition of the peripheral-type benzodiazepine receptor expression and cell proliferation in human breast cancer cellsV Papadopoulos, A Kapsis, H Li, et al.
The Journal of Clinical Endocrinology and Metabolism|March 7, 2001
Bim-23244, a somatostatin receptor subtype 2- and 5-selective analog with enhanced efficacy in suppressing growth hormone (GH) from octreotide-resistant human GH-secreting adenomasA Saveanu, G Gunz, H Dufour, et al.
Pageof 57